RecruitingNot ApplicableNCT06224426

Oxygen Concentration Target in Stroke Endovascular Treatment

Oxygenation Targets for Endovascular Therapy in Acute Ischemic Stroke Patients (Oxy-TARGET)


Sponsor

Beijing Tiantan Hospital

Enrollment

200 participants

Start Date

Feb 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to compare the effects of different concentrations of normobaric oxygen on early neurological improvement in acute ischemic stroke (AIS) patients receiving endovascular therapy (EVT). The main questions it aims to answer are: * Evaluating the impact of normobaric high-concentration oxygen versus low-concentration oxygen on early neurological function after EVT. * Evaluating the safety of high and low normobaric oxygen concentration in patients with ischemic stroke. Participants will (1) receive EVT under general anesthesia; (2) be randomly assigned 1:1 to receive oxygen therapy with FiO2=80% or FiO2=30% through endotracheal intubation during the operation, and the gas flow rate was set at 4L /min.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Age ≥18 years.
  • Anterior circulation occlusive stroke is confirmed by CT angiography (CTA), magnetic resonance angiography (MRA) or digital subtraction angiography (DSA), and occlusions of intracranial internal carotid artery (ICA) or M1 segment of the middle cerebral artery (MCA) were involved.
  • NIHSS score at admission: 6-20.
  • Randomization can be completed within 24 hours after stroke onset.

Exclusion Criteria10

  • Stroke onset within 6-24 hours with a CT perfusion imaging (CTP)-assessed mismatched area<15 ml.
  • Presence of anemia, defined as hemoglobin levels o below 120 g/L in men and below 110 g/L in women.
  • Pre-stroke modified Rankin scale (mRS) score ≥2.
  • Complicated by severe agitation and seizures.
  • Evidence of intracranial hemorrhage at admission.
  • Presence of chronic obstructive pulmonary disease, asthma, or other respiratory conditions, or requirement for daily supplemental oxygen or mechanical ventilation.
  • Baseline arterial blood gas analysis indicating impaired gas exchange: PaO2 < 60 mmHg on room air, or oxygenation index (PaO2/FiO2) < 300 mmHg with supplemental oxygen.
  • Emergency chest CT reveals significant pulmonary parenchymal infection.
  • An oxygen mask or ventilator must be used before anesthesia to maintain a SpO2≥94%.
  • Loss of airway protective reflex or vomiting aspiration upon admission.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNormobaric high-concentration oxygen

During endovascular therapy, eligible participants will receive FiO2=80% through endotracheal intubation, with a gas flow rate set at 4 L/min.

OTHERNormobaric low-concentration oxygen

During endovascular therapy, eligible participants will receive FiO2=30% through endotracheal intubation, with a gas flow rate set at 4 L/min.


Locations(1)

Beijing Tiantan Hospital, Capital Medical University

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06224426


Related Trials